These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6334491)

  • 1. Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species.
    Aldridge KE; Sanders CV; Janney A; Faro S; Marier RL
    Antimicrob Agents Chemother; 1984 Sep; 26(3):410-3. PubMed ID: 6334491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the in vitro inhibitory and bactericidal activity of ceftizoxime, cefoxitin, cefotetan, and penicillin G against Bacteroides fragilis group isolates. Comparison of time-kill kinetic studies with MIC values.
    Aldridge KE; Weeks LS; Stratton CW; Sanders CV
    Diagn Microbiol Infect Dis; 1990; 13(4):311-6. PubMed ID: 2076592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of Bacteroides fragilis group susceptibility patterns in Canada.
    Bourgault AM; Lamothe F; Hoban DJ; Dalton MT; Kibsey PC; Harding G; Smith JA; Low DE; Gilbert H
    Antimicrob Agents Chemother; 1992 Feb; 36(2):343-7. PubMed ID: 1605600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
    O'Keefe JP; Venezio FR; DiVincenzo CA; Shatzer KL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2002-4. PubMed ID: 3439807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns.
    Aldridge KE; Ashcraft D; O'Brien M; Sanders CV
    Antimicrob Agents Chemother; 2003 Jan; 47(1):148-53. PubMed ID: 12499183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
    Downes J; Andrew JH
    Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin.
    Eley A; Greenwood D
    Antimicrob Agents Chemother; 1981 Sep; 20(3):332-5. PubMed ID: 6272629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antibiotic sensitivity of the Bacteroides fragilis group in the United Kingdom.
    Fox AR; Phillips I
    J Antimicrob Chemother; 1987 Oct; 20(4):477-88. PubMed ID: 3680088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains.
    Nagy E; Szóke I; Gacs M; Csiszár K
    Acta Microbiol Immunol Hung; 1995; 42(3):287-99. PubMed ID: 8548202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
    Appelbaum PC; Spangler SK; Jacobs MR
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactamase activity of anaerobic bacteroides strains isolated from clinical samples and their susceptibility to antimicrobial agents.
    Uraz G; Türkmen L
    Drug Metabol Drug Interact; 1999; 15(2-3):181-6. PubMed ID: 10707123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance.
    Appelbaum PC; Philippon A; Jacobs MR; Spangler SK; Gutmann L
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2169-76. PubMed ID: 2073107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan.
    Watanabe K; Ueno K; Kato N; Muto Y; Bandoh K; Tanaka Y; Jotwani R; Goto M; Shimada K; Shimizu K
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1069-73. PubMed ID: 1295761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility.
    Lacroix JM; Lamothe F; Malouin F
    Antimicrob Agents Chemother; 1984 Nov; 26(5):694-8. PubMed ID: 6335019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
    Goldstein EJ; Citron DM
    J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and susceptibility of resistant Bacteroides fragilis group organisms to new beta-lactam antibiotics.
    Heseltine PN; Appleman MD; Leedom JM
    Rev Infect Dis; 1984; 6 Suppl 1():S254-9. PubMed ID: 6585882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.
    Cuchural GJ; Tally FP; Jacobus NV; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP; Pierson C
    Antimicrob Agents Chemother; 1990 Mar; 34(3):479-80. PubMed ID: 2334161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group].
    Dusart G; Simeon de Buochberg M; Zuccarelli M; Attisso MA; Willemin C
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):523-7. PubMed ID: 2797878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
    Brook I; Coolbaugh JC; Walker RI; Weiss E
    Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.